Procept Biorobotics
PRCT
202 hedge funds and large institutions have $2.69B invested in Procept Biorobotics in 2024 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 78 increasing their positions, 50 reducing their positions, and 13 closing their positions.
323% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 13
300% more funds holding in top 10
Funds holding in top 10: 2 → 8 (+6)
56% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 50
25% more funds holding
Funds holding: 162 → 202 (+40)
19% more capital invested
Capital invested by funds: $2.26B → $2.69B (+$424M)
1% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $20M
4.63% less ownership
Funds ownership: 90.13% → 85.5% (-4.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$49M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$25.7M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$24.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
CPMG Inc
Dallas,
Texas
|
-$260M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$70.9M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$22.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.9M |
PRCT Hedge Fund Activity: Q2 2024 in Review
202 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2024, worth a combined $2.69B — up 19% from $2.26B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PRCT positions and 13 closed out — a net gain of 42 holders — while 78 added to existing stakes and 50 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $49M. The largest seller was CPMG Inc, cutting an estimated $260M.
- 202 institutional investors held Procept Biorobotics (PRCT) as of Q2 2024, up from 162 in Q1 2024.
- Funds reported $2.69B of Procept Biorobotics stock for Q2 2024, up 19% quarter-over-quarter.
- 55 funds opened new Procept Biorobotics positions in Q2 2024 and 13 closed out, a net change of +42 holders.
- The largest Procept Biorobotics buyer in Q2 2024 was JP Morgan Chase, an estimated $49M added.
- The largest Procept Biorobotics seller in Q2 2024 was CPMG Inc, an estimated $260M sold.
Based on aggregated 13F filings for Q2 2024.